Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Nature Genetics|December 2, 1999
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosisC Toomes, J James, A J Wood, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 19, 2025
Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancerRyan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trialRaghav Sundar, Alvin Ng, Hermioni Zouridis, et al.
Journal of the Endocrine Society|June 7, 2023
A Novel Mouse Model to Analyze Non-Genomic ERα Physiological ActionsYukitomo Arao, Artiom Gruzdev, Gregory J Scott, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Development of methyl isoxazoleazepines as inhibitors of BETMichael C Hewitt, Yves Leblanc, Victor S Gehling, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET BromodomainsAlexander M Taylor, Rishi G Vaswani, Victor S Gehling, et al.
Nature Communications|June 8, 2021
A recombined Sr26 and Sr61 disease resistance gene stack in wheat encodes unrelated NLR genesJianping Zhang, Timothy C Hewitt, Willem H P Boshoff, et al.
The Journal of Biological Chemistry|January 31, 2018
Estrogen receptor α protects pancreatic β-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stressZhenqi Zhou, Vicent Ribas, Prashant Rajbhandari, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery, Design, and Optimization of Isoxazole Azepine BET InhibitorsVictor S Gehling, Michael C Hewitt, Rishi G Vaswani, et al.
Journal of Medicinal Chemistry|January 28, 2016
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical TrialsBrian K Albrecht, Victor S Gehling, Michael C Hewitt, et al.
Pageof 25